Nathalie Belmonte
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Nathalie Belmonte
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
19
| Subsidiary | Miscellaneous Commercial Services | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nathalie Belmonte tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Chairman Public Communications Contact | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
Fournitures Hospitalières SAS
 Fournitures Hospitalières SAS Financial ConglomeratesFinance Fournitures Hospitalières SAS operates as a holding company with interests in the distribution of orthopedic, cardiovascular, and surgical equipment and supplies. The company was founded by André Hermann in 1964 and is headquartered in Heimsbrunn, France. | Financial Conglomerates | Director/Board Member | |
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Founder | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
PALUMED SA
 PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor | |
| EOS IMAGING | Medical Specialties | Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
InGen Biosciences SA
 InGen Biosciences SA Medical SpecialtiesHealth Technology InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France. | Medical Specialties | Director/Board Member | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
| MEDTECH | Electronic Equipment/Instruments | Director/Board Member | |
PricewaterhouseCoopers France SARL
 PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers France provides accounting and business management consulting services. It offers expertise in auditing, financial strategy, legal advise, and investment. The company was founded on May 30, 1963 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman | |
| Theralpha | Director/Board Member | ||
| ELSALYS BIOTECH | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
Loxbridge Research LLP
 Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Agalimmune Ltd.
 Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Director/Board Member | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
Resolys Bio, Inc.
 Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chief Executive Officer | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
Cytoseek Ltd.
 Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Pepgen Ltd.
 Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chairman | |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| Treehill Partners, LLC | Corporate Officer/Principal | ||
Imophoron Ltd.
 Imophoron Ltd. BiotechnologyHealth Technology Imophoron Ltd. is an American company that specializes in cutting-edge vaccine development. The company's scientific advisory board consists of world-leading experts in vaccine technology and infectious diseases. The company is constantly exploring new and innovative ways to combat infection using the latest techniques from science and technology. More information about the company can be found on their website at www.imophoron.com. The company was founded by Fred Garzoni and Richard Edward Bungay has been the CEO of the company since 2022. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Francia | 26 |
| Regno Unito | 10 |
| Stati Uniti | 7 |
| Belgio | 3 |
| Norvegia | 3 |
Settori
| Health Technology | 28 |
| Commercial Services | 6 |
| Finance | 6 |
| Consumer Services | 4 |
| Electronic Technology | 3 |
Posizioni
| Director/Board Member | 132 |
| Corporate Officer/Principal | 44 |
| Chief Executive Officer | 23 |
| Chairman | 20 |
| Independent Dir/Board Member | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Emmanuel Fiessinger | 52 |
| Stéphane Boissel | 24 |
| Bernard Daugeras | 23 |
| Damian Marron | 23 |
| David Solomon | 22 |
| Laurent Arthaud | 21 |
| François Meyer | 20 |
| Marie-Laure Garrigues | 19 |
| Marie-Yvonne Landel-Meunier | 13 |
| Miguel Forte | 12 |
| Catherine Mathis | 6 |
| Christophe Sarlot | 5 |
| Raphael Flipo | 4 |
| Virginie Neveu | 4 |
| Eric Pottier | 3 |
- Borsa valori
- Insiders
- Nathalie Belmonte
- Connessioni Società
